Got to love this bit that was published in the Adelaide Advertiser yesterday reporting on the results....
"Invion is targeting a multi-billion dollar market segment that already has two existing drugs - from GlaxoSmithkline and Pfizer. However, the results from Invion's study indicate its success rate is in the ballpark with that of the two pharma majors offerings, but has lower side-effects, Dr Collier said."
The press out there is good
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.59M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 12.5¢ | $15.62K | 118.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 213400 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 57707 | 2 |
View Market Depth
| Last trade - 14.46pm 20/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |